Hypera SA - Company Profile
Powered by 
All the data and insights you need on Hypera SA in one report.
$295
- Save hours of research time and resources with
our up-to-date Hypera SA Strategy Report
- Understand Hypera SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Hypera SA’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 13 Jul 2021 | Sanofi to Sell Eight Brands to Hypera | Asset Transaction |
Hypera SA
|
Sanofi |
| 26 Sep 2020 | Uniao Quimica Farmaceutica to Acquire Xantinon from Hypera | Asset Transaction |
Uniao Quimica Farmaceutica Nacional SA
|
Hypera SA |
| 26 Sep 2020 | Uniao Quimica Pharma Acquires Xantinon from Hypera | Asset Transaction |
Uniao Quimica Farmaceutica Nacional SA
|
Hypera SA |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer